Brussels, 19 October 2010 – NYSE Liffe, the Europe-based derivatives business of NYSE Euronext (NYX) today announced that after regulatory approval of their respective regulators, the AFM and the CBFA, rules and trading procedures of the Amsterdam and Brussels derivatives markets have been harmonised.
This harmonisation is based on the successful Amsterdam market model. It aims at allowing an enhanced access of the Brussels derivatives market for more market participants, like on screen market makers and retail flow providers. With the introduction of the Prof Trade facility in the Brussels derivatives market, professional market participants are offered a flexible mechanism to trade wholesale size in a regulated environment without counterparty risk.